Lv1
80 积分 2022-01-11 加入
Genomic alterations, molecularly targeted therapy, and survival: A real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study
6天前
已完结
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition
7天前
已完结
Activated PARP1/FAK/COL5A1 signaling facilitates the tumorigenesis of cholesterol-resistant ovarian cancer cells through promoting EMT
7天前
已完结
The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1
7天前
已完结
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
8天前
已完结
Isatin-indoloquinoxaline click adducts with a potential to overcome platinum-based drug-resistance in ovarian cancer
8天前
已完结
REG3A promotes proliferation and DDP resistance of ovarian cancer cells by activating the PI3K/Akt signaling pathway
8天前
已完结
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potential
8天前
已完结
A new approach to the treatment of ovarian cancer: the application of CAR-T cell therapy
8天前
已完结
Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer
8天前
已完结
皖公网安备34019202002308
